Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.45 |
| ▸ | MDH1 | P40925 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15963129 | 0.94 | CYP4A11 (0.53) | CYP4A11CYP4F2GPR84PTGS2MDH1 | |
| SCHEMBL25340179 | 0.91 | GPR84 (0.54) | CYP4A11CYP4F2GPR84PTGS2MDH1 | |
| SCHEMBL27410721 | 0.89 | PTGS2 (0.55) | GPR84PTGS2THRATHRBPPARA | |
| SCHEMBL16247137 | 0.87 | CYP4A11 (0.51) | CYP4A11CYP4F2GPR84MDH1 | |
| SCHEMBL28410139 | 0.85 | GPR84 (0.59) | GPR84PTGS2THRATHRBPPARA | |
| SCHEMBL16955938 | 0.84 | CYP4A11 (0.47) | CYP4A11CYP4F2GPR84MDH1 | |
| SCHEMBL19259022 | 0.84 | CYP4A11 (0.51) | CYP4A11CYP4F2GPR84MDH1 | |
| SCHEMBL7110194 | 0.82 | CYP4A11 (0.48) | CYP4A11CYP4F2GPR84PTGS2MDH1 | |
| SCHEMBL17367305 | 0.81 | PLA2G2A (0.59) | — | |
| SCHEMBL15174508 | 0.79 | CYP4F2 (0.76) | CYP4A11CYP4F2MDH1PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170313652-A1 | Poly-Cyanostilbene Macrocycles | NATIONAL SCIENCE FOUNDATION | 2017-11-02 | — | — | US | disclosed |
| US-9701621-B2 | Poly-cyanostilbene macrocycles | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2017-07-11 | — | — | US | disclosed |
| US-20150376122-A1 | Poly-Cyanostilbene Macrocycles | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376122-A1 | Poly-Cyanostilbene Macrocycles | PCBP1, HCCS, ACVR2B | CYP4A11 2928/4885CYP4F2 730/4885GPR84 3230/4885 |
| US-20170313652-A1 | Poly-Cyanostilbene Macrocycles | PCBP1, HCCS, ACVR2B | CYP4A11 2928/4885CYP4F2 730/4885GPR84 3230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.